已收盤 02-06 16:00:00 美东时间
+1.220
+4.25%
Ambiq Micro (NYSE:AMBQ) sees FY2025 sales of $71.770 million-$72.470 million vs $69.457 million analyst estimate.
01-21 21:22
Ambiq Micro, Inc. ("Ambiq") (NYSE:AMBQ), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the commencement of an underwritten public offering of 2,200,000 shares of its common
01-21 21:02
BofA Securities says U.S. semiconductor stocks have strong tailwinds as AI demand rises and chip sales head toward a $1 trillion milestone.
01-09 02:06
Austin, Texas-based Ambiq Micro, Inc., a leader in ultra-low-power semiconductors, unveiled Atomiq®, the world's first ultra-low-power NPU SoC built on its SPOT® platform. Designed to enable real-time, always-on AI at the edge, Atomiq features the Arm® Ethos™-U85 NPU, delivering over 200 GOPS of performance for tasks like vision, speech, and reasoning. Its dynamic power scaling and robust software platform, Helia™, aim to revolutionize energy eff...
01-06 13:30
U.S. stock futures were mostly flat this morning, with the Dow futures gaining ...
2025-12-30 21:03
根据美国证券交易委员会(SEC)披露,软银递交了截至2025年9月30日的第三季度持仓报告(13F)。
2025-11-17 15:59
Ambiq Micro (NYSE:AMBQ) is looking for Q4 Adj EPS of $(0.44)-$(0.34) vs $(0.42) analyst estimate. sees sales of $18.500 million-$19.500 million vs $14.217 million analyst estimate.
2025-11-07 05:41
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
2025-10-28 10:08
UBS analyst Timothy Arcuri maintains Ambiq Micro (NYSE:AMBQ) with a Neutral and lowers the price target from $40 to $32.
2025-10-28 02:12
Ambiq Micro的Subthreshold Power Optimized Technology (SPOT®)平台被《时代》杂志评为2025年度最佳发明之一,在人工智能类别中被认可为技术突破,使设备在极低功耗下高效运行AI任务。该平台自2010年起研发,已应用于全球2.8亿多设备,涵盖智能穿戴、医疗监测和物联网等领域。
2025-10-09 13:30